In a startling development, medical experts have warned of the rapid spread of a virus exhibiting symptoms similar to COVID-19 and influenza. This pathogen causes lower lung infections, persistent coughs, runny noses, sore throats, and fevers. This development has puzzled scientists, as it is distinct from the coronavirus strain.
“That peak itself is about 36% higher than what is normally seen before the pandemic,” said Dr. Bruce Lee.— The Epoch Times (@EpochTimes) June 1, 2023
Human metapneumovirus, or hMPV, has risen across the US this winter and spring, according to recent #CDC data. https://t.co/YuTJBK16JR
Recent reports from the CDC’s respiratory virus surveillance systems reveal a concerning rise in Human Metapneumovirus (HMPV) cases. Hospitals across the US and other nations like Australia and Spain are finding their ICUs teeming with young children and vulnerable elderly, who appear to be getting hit hard with this infection.
Disturbingly, in Mid-March, HMPV infections reached an alarming 11%, a staggering 36% increase compared to the pre-pandemic seasonal peak of 7%.
Dr. John Williams, a renowned Pediatrician at the University of Pittsburgh, has dedicated his career to studying and researching viruses and vaccines. He deems HMPV as “the most important virus you have never heard of.”
He asserts: “HMPV, alongside flu and respiratory syncytial virus (RSV), poses one of the gravest risks for hospitalization and mortality.”
Regrettably, due to limited testing, the true extent of fatalities and infections caused by this virus remains unknown. However, a notable rise in cases, predominantly affecting children under five, is worrisome. Compounding the concern is the absence of approved drugs or vaccines to combat HMPV.
Symptoms associated with the HMPV virus include coughs, runny noses, sore throats, and fevers. In severe cases, patients may struggle to breathe, experience bronchitis, or even develop pneumonia. Infants and elderly are particularly susceptible due to their weakened immune systems.
Transmission occurs through close contacts, such as coughing, handshakes, sneezing, or contact with contaminated objects or surfaces. Moderna, a prominent COVID-19 vaccine manufacturer, has recently concluded an early study on an mRNA vaccine targeting HMPV and influenza.
In light of these developments, the CDC strongly advises doctors to consider testing for HMPV during the winter and spring seasons when the virus tends to peak.